Cardiac Diagnostics

This channel includes news, videos, podcasts and other content on new technology innovations for cardiac diagnostic systems and techniques. This includes laboratory testing, blood tests including troponin testing, electrocardiogram (ECG) systems, point of care testing systems, genetic testing, cardiac patient monitoring devices including wearable sensors, and studies showing new ways to diagnose heart diseases.

The companies will jointly support a series of educational forums among clinicians beginning later this year highlighting the significant new scientific breakthroughs that are radically transforming the traditional approach to heart disease prevention and prediction
News | Pharmaceuticals
Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil
Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
A public-private partnership Think Tank
News | Cardiovascular Education
Cardiac Safety Research Consortium Announces Think Tank Program with FDA Regulators, Industry and Academia Focused on Cardiac Remote Monitoring Trials and AI

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the Card ...

Home January 15, 2024
Home
Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the detection of cardiac amyloidosis.
News | Artificial Intelligence
Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

January 15, 2024 — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the ...

Home January 15, 2024
Home
New research from Mayo Clinic suggests that AI could improve the diagnosis of peripartum cardiomyopathy
News | Artificial Intelligence
Clinical Research Shows AI-enabled Digital Stethoscope can Detect Pregnancy-related Heart Disease

January 9, 2024 — New research from Mayo Clinic suggests that artificial intelligence (AI) could improve the diagnosis ...

Home January 09, 2024
Home
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally
News | Wearables
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System

January 3, 2024 — iRhythm Technologies, Inc., a leading digital health care company focused on creating trusted ...

Home January 03, 2024
Home
This patient milestone and the recent launch of Plaque Analysis and RoadMap Analysis further solidify HeartFlow as a pioneer in AI-enabled CAD diagnostics
News | FFR Technologies
HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis

January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care ...

Home January 03, 2024
Home
Results from an ongoing clinical study conducted by Scripps Clinic indicate that MindMics' non-invasive IH technology can detect aortic stenosis by capturing in-ear acoustic vibrations throughout the cardiac cycles
News | Patient Monitors
MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new ...

Home December 26, 2023
Home
Company appoints Mohammad Shokoohi-Yekta to lead program and industry pioneer Lance Myers as advisor
News | Artificial Intelligence
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

December 22, 2023 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power ...

Home December 22, 2023
Home
ECGI vest developed at UCL being worn by a UCL medical student
News | Sudden Cardiac Arrest
Heart Vest Could Help Predict Sudden Cardiac Death Risk

December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to ...

Home December 19, 2023
Home
News | Cardiovascular Clinical Studies
Clinical Trial Results from Peerbridge Health Unveil Direct-from-ECG Sleep Apnea Detection Using COR Wearable Platform

December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective ...

Home December 19, 2023
Home
Early detection of atrial fibrillation can reduce the risk of stroke and heart failure, but screening people for the condition has been historically challenging
News | Atrial Fibrillation
New AI-powered Algorithm Could Better Assess People’s Risk of Common Heart Condition

December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help ...

Home December 13, 2023
Home
As coronary computed tomography angiography (CCTA) progresses towards becoming the primary imaging modality for not only diagnostic purposes, but also for clinical trial endpoints, there is a need to address the requirements for generating high-quality CCTA image data to ensure accurate and robust CAD assessments
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD
From the Clinic to Pharmaceutical Clinical Trials: Considerations for using Coronary CT Angiography (CCTA) in Atherosclerotic Cardiovascular Disease (ASCVD) Clinical Trials

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
The device would be the first clinical-grade, diagnostic wrist-worn device for long term Afib monitoring
News | Wearables
Clinical Smartwatch Finds Success at Identifying Atrial Fibrillation

December 1, 2023 — As the use of wearable technology grows, smartwatches are marketed across the globe to consumers as a ...

Home December 01, 2023
Home
A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems
News | Artificial Intelligence
Renal HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms

November 22, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical ...

Home November 22, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now